Philips to buy Spectranetics

Published on: 28 Jun, 2017

Koninklijke Philips N.V. (NYSE: PHG), or better known as Philips, a Dutch technology company focused in electronics, healthcare, and lighting, has agreed to buy Spectranetics Corp. (NASDAQ: SPNC), a US based medical device company, for $1.7B euros to improve  its image-guided therapy field.

Philips will be paying Spectranetics shareholders at $38.50 per share, which represents around 27% premium on Spectranetics’ closing share price on Tuesday.  Shares of Spectranetics Corp., SPNC, surged rapidly since this morning trade on Wednesday at +26.23%, up $7.98 to $38.38. Philips expects Spectranetics to make sales of $300 million for the year, and is expecting growth revenues of double-digit rates in 2018.

This acquisition shows that leaders at Philips is hoping to expand its health care sector as seven of Philip’s ten biggest financial deals have been in health. Philip’s presence is further strengthened by its previous acquisition of Volcano, a vascular imaging company, in 2015. Overall, shares of Philips in the past year has been returning, including a $6 increase in the last 6 months.  


  • 3177Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Steven Liao



Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

19 Jul, 2017 2963
14 Aug, 2017 3122
29 Aug, 2017 2630
10 Oct, 2017 2746


There is no comment on this article